• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (III)--Teratological study in rabbits by oral administration].

作者信息

Shinomiya M, Yukiyama S, Ikebuchi K

机构信息

Drug Safety Research Laboratory, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan.

出版信息

J Toxicol Sci. 1996 Nov;21 Suppl 3:619-41. doi: 10.2131/jts.21.supplementiii_619.

DOI:10.2131/jts.21.supplementiii_619
PMID:9021665
Abstract

S-1 is a newly developed antineoplastic agent consisting of the mixture of tegafur (FT), 5-chloro-2, 4-dihydroxypyridine (CDHP), and potassium oxonate (Oxo) in a molar ratio of 1:0.4:1. As part of a reproductive and developmental toxicity study of S-1, a teratogenicity study was carried out in rabbits administered daily oral doses of S-1 0, 0.5, 1, or 1.5 mg/kg/day (as a dose of FT). S-1 was administered from day 6 to day 18 of pregnancy. Two additional studies were conducted in order to evaluate the effect on embryos or fetuses at higher S-1 dosage. One study (additional study I) tested during organogenesis dividing it into 3 periods (Day 6-10, Day 10-14, and Day 14-18) at doses of 2, 4 or 6 mg/kg/day. Another study (additional study II) tested during organogenesis dividing it into 4 periods (Day 8 x 9, Day 10 x 11, Day 12 x 13, and Day 14 x 15) at doses of 3 or 6 mg/kg/day due to many embryo deaths at high dose level in the additional study I. The results were as follows. 1. Teratogenicity study One dam died on day 16 of pregnancy and there was a weak teratogenic potential in the 1.5 mg/kg/day group. There were no remarkable other changes in dams and fetuses. The non-observed effects dose level of S-1 for general toxicity in dams was 1 mg/kg/day, for pregnancy in dams was 1.5 mg/kg/day, and for development of fetuses was 1 mg/kg/day under the conditions of this study. 2. Additional study I Abortion was observed at 6 mg/kg/day in the day 14-18 administration group. General toxicity in dams were observed in all administration groups. Fetal lethality was observed at 4 mg/kg/day or more in the day 6-10 and day 10-14 groups, and at 6 mg/kg/day in the day 14-18 administration group. Inhibition of fetal growth was observed at 2 mg/kg/day in the day 10-14 group and at 2 mg/kg/day or more in the day 14-18 administration group. There was a week teratogenic potential at 2 mg/kg/day or more in the day 10-14 groups and at 4 mg/kg/day in the day 14-18 administration group. 3. Additional study II Abortion was observed at 6 mg/kg/day in the day 8-9, day 10-11, and day 12-13 administration groups. General toxicity in dams were observed in all administration groups. Fetal lethality was observed at 3 mg/kg/day in the day 8-9 group and at 6 mg/kg/day in all administration groups. Inhibition of fetal growth and teratogenic potential were clearly observed at 3 mg/kg/day in the day 8-9 and day 10-11 groups, and at 6 mg/kg/day in the day 12-13 and day 14-15 administration groups. 4. In conclusion, when S-1 was administered at a low dose (< = or 1.5 mg/kg/day) during organogenesis effects were not detected clearly. When higher doses were administered (2-6 mg/kg/day), fetal lethality, inhibition of fetal growth, and teratogenicity were observed.

摘要

相似文献

1
[Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (III)--Teratological study in rabbits by oral administration].
J Toxicol Sci. 1996 Nov;21 Suppl 3:619-41. doi: 10.2131/jts.21.supplementiii_619.
2
[Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (II)--Teratological study in rats by oral administration].
J Toxicol Sci. 1996 Nov;21 Suppl 3:603-18. doi: 10.2131/jts.21.supplementiii_603.
3
[Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (I)--Fertility study in rats by oral administration].
J Toxicol Sci. 1996 Nov;21 Suppl 3:589-602. doi: 10.2131/jts.21.supplementiii_589.
4
[Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (IV)--Perinatal and postnatal study in rats by oral administration].
J Toxicol Sci. 1996 Nov;21 Suppl 3:643-59. doi: 10.2131/jts.21.supplementiii_643.
5
[An oral repeated dose toxicity study of a new antineoplastic agent S-1 in dogs. I. A 13-week repeated dose toxicity study. II. An ophthalmologic toxicity recovery study].[新型抗肿瘤药物S-1对犬的口服重复给药毒性研究。I. 13周重复给药毒性研究。II. 眼科毒性恢复研究]
J Toxicol Sci. 1996 Nov;21 Suppl 3:527-44. doi: 10.2131/jts.21.supplementiii_527.
6
[A 13-week oral repeated dose toxicity study of a new antineoplastic agent S-1 in rats].新型抗肿瘤药物S-1对大鼠的13周口服重复给药毒性研究
J Toxicol Sci. 1996 Nov;21 Suppl 3:505-26. doi: 10.2131/jts.21.supplementiii_505.
7
[Oral single-dose toxicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
J Toxicol Sci. 1996 Nov;21 Suppl 3:495-504. doi: 10.2131/jts.21.supplementiii_495.
8
[A 26-week oral repeated dose toxicity study of a new antineoplastic agent S-1 in rats].
J Toxicol Sci. 1996 Nov;21 Suppl 3:545-60. doi: 10.2131/jts.21.supplementiii_545.
9
[Reproductive and developmental toxicity studies of taltirelin hydrate (3) teratogenicity study in rabbits by oral administration].[水合他替瑞林(3)对家兔经口给药的生殖和发育毒性研究及致畸性研究]
J Toxicol Sci. 1997 Nov;22 Suppl 2:395-403. doi: 10.2131/jts.22.supplementii_395.
10
[Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (3)--Teratological study in rabbits by oral administration].[甲苯磺酸舒普拉特(IPD - 1151T)的生殖与发育毒性研究(3)——家兔口服给药的致畸学研究]
J Toxicol Sci. 1992 May;17 Suppl 2:175-85. doi: 10.2131/jts.17.supplementii_175.